Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

NCT00812318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection
Infection, Human Immunodeficiency Virus

Interventions

DRUG: GSK1265744 10 mg oral solution
DRUG: GSK1265744 5 mg tablet
DRUG: GSK1265744 5 mg tablet

Sponsor

ViiV Healthcare

Collaborators

[object Object]
[object Object]